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Abstract
Background: Selective reporting of outcomes in clinical trials is a serious problem. We aimed to investigate the
influence of the peer review process within biomedical journals on reporting of primary outcome(s) and statistical
analyses within reports of randomised trials.
Methods: Each month, PubMed (May 2014 to April 2015) was searched to identify primary reports of randomised
trials published in six high-impact general and 12 high-impact specialty journals. The corresponding author of each
trial was invited to complete an online survey asking authors about changes made to their manuscript as part of
the peer review process. Our main outcomes were to assess: (1) the nature and extent of changes as part of the
peer review process, in relation to reporting of the primary outcome(s) and/or primary statistical analysis; (2) how
often authors followed these requests; and (3) whether this was related to specific journal or trial characteristics.
Results: Of 893 corresponding authors who were invited to take part in the online survey 258 (29%) responded.
The majority of trials were multicentre (n = 191; 74%); median sample size 325 (IQR 138 to 1010). The primary
outcome was clearly defined in 92% (n = 238), of which the direction of treatment effect was statistically significant
in 49%. The majority responded (1–10 Likert scale) they were satisfied with the overall handling (mean 8.6, SD 1.5)
and quality of peer review (mean 8.5, SD 1.5) of their manuscript. Only 3% (n = 8) said that the editor or peer
reviewers had asked them to change or clarify the trial’s primary outcome. However, 27% (n = 69) reported they
were asked to change or clarify the statistical analysis of the primary outcome; most had fulfilled the request, the
main motivation being to improve the statistical methods (n = 38; 55%) or avoid rejection (n = 30; 44%). Overall,
there was little association between authors being asked to make this change and the type of journal, intervention,
significance of the primary outcome, or funding source. Thirty-six percent (n = 94) of authors had been asked to
include additional analyses that had not been included in the original manuscript; in 77% (n = 72) these were not
pre-specified in the protocol. Twenty-three percent (n = 60) had been asked to modify their overall conclusion,
usually (n = 53; 88%) to provide a more cautious conclusion.
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Conclusion: Overall, most changes, as a result of the peer review process, resulted in improvements to the
published manuscript; there was little evidence of a negative impact in terms of post hoc changes of the primary
outcome. However, some suggested changes might be considered inappropriate, such as unplanned additional
analyses, and should be discouraged.
Keywords: Randomised controlled trials, Selective outcome reporting, Peer review
Background
Peer review is considered fundamental to the integration of
new research findings into the scientific community [1].
Journal editors rely on the views of independent experts
(peer reviewers) in making decisions on the publication of
submitted manuscripts [2] and peer review is widely con-
sidered necessary for evaluating the credibility of published
research. Worldwide, peer review costs an estimated £1.9
billion annually and accounts for around one quarter of the
overall costs of scholarly publishing and distribution [3].
Despite this huge investment and widespread accept-
ance of the peer review process by the scientific commu-
nity, little is known about its impact on the quality of
reporting of published research [4, 5]. Studies have
shown that peer reviewers are not able to appropriately
detect errors [6–8], improve the completeness of report-
ing [9], or decrease the distortion of the study results
[10]. One such study evaluating the impact of peer re-
view found that although peer reviewers often detect im-
portant deficiencies in the reporting of the methods and
results of randomised trials they miss more omissions
than they detect [9]. That study showed that on average
peer reviewers requested few changes. Most changes
were deemed by the authors to have had a positive im-
pact on reporting of the final publication; for example,
clarification of the primary and secondary outcomes or
the toning down of conclusions to reflect the results.
However, some changes requested by peer reviewers
were deemed inappropriate and could have a negative
impact on reporting of the final publication, such as the
adding of unplanned post hoc additional analyses.
In this study, we investigated the influence of the peer
review process within biomedical journals on the report-
ing of primary outcome(s) and statistical analyses within
published reports of randomised trials. In particular, we
examined how often relevant post hoc changes of the pri-
mary outcome(s) and/or the primary statistical analysis
were requested, how often the authors followed these re-
quests, and whether the frequency of these suggestions
was related to specific journal or trial characteristics.
Methods
Sample selection
We searched the US National Library of Medicine’s
PubMed database over a 1 year period to identify all
primary reports of randomised trials published between
May 2014 to April 2015 in the six general medical jour-
nals and 12 specialty journals with the highest ISI impact
factor in 2012. The six general medical journals were the
New England Journal of Medicine, Lancet, JAMA, BMJ,
PLoS Medicine and Annals of Internal Medicine. The top
12 specialty journals (Table 1) were identified from the
major ISI Web of Knowledge journal citation reports
medical subject categories. We restricted inclusion to
journals that had published at least 50 articles in 2013
with the Publication Type term ‘Randomized Controlled
Trial’ (based on a PubMed search on 7 April 2014) (see
Additional file 1).
Table 1 Identification of primary reports of randomised
controlled trials (RCTs) (May 2014 to April 2015) and number of
authors responding to the online survey
Journal Number
of RCTs
Survey
completed
% survey
completed
General
Annals of Internal Medicine 18 6 33%
BMJ 31 13 42%
JAMA 76 20 26%
Lancet 85 28 33%
New England Journal of Medicine 134 45 34%
PLoS Medicine 16 9 56%
Specialty
Anesthesia and Analgesia 34 9 26%
Annals of Rheumatic Diseases 42 12 29%
British Journal of Anaesthesia 39 19 49%
Circulation 22 9 41%
Diabetes Care 84 12 14%
Journal of the American College
of Cardiology
27 3 11%
Journal of Clinical Oncology 70 19 27%
Journal of Infectious Diseases 23 6 26%
Journal of Pediatrics 31 7 23%
Lancet Oncology 75 20 27%
Pediatrics 59 14 24%
Stroke 27 7 26%
Total 893 258 29%
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We developed a search strategy based on a modified
version of the Cochrane highly sensitive search strategy
(see Additional file 2). The search was run monthly to
identify reports of randomised trials published in the
previous month (e.g. the search was performed in the
third week of June 2014 for all articles published in the
print version of each journal in May 2014). One reviewer
(SH) screened the titles and abstracts of all retrieved
reports to exclude any obvious reports of ineligible trials.
A copy of the full article was then obtained for all non-
excluded reports, and assessed by two reviewers to
determine if it met the inclusion criteria.
Eligibility criteria
We included all primary reports (that is, those reporting
the main study outcome) of randomised trials, defined
as a prospective study assessing healthcare interventions
in human participants who were randomly allocated to
study groups. We included all studies of parallel-group,
crossover, cluster, factorial and split-body design. We ex-
cluded protocols of randomised trials, secondary ana-
lyses, systematic reviews, methodological studies, pilot
studies and early phase (phase 1) trials.
Online survey
We sent an invitation email (see Additional file 3) to the
corresponding author of each eligible report of a rando-
mised trial identified from our search. These authors were
asked to participate in an online survey investigating the
type of changes made to manuscripts of randomised trials
as part of the peer review process. If they agreed to partici-
pate, an Internet link included in the invitation email gave
them access to the online survey. Participants were asked
to confirm that they agreed to participate before being
able to complete the online survey. The online survey was
tested by members of the study team to ensure compre-
hension of the survey questions.
The survey consisted of short questions, which asked
them to rate on a 1–10 Likert scale the overall handling
of their manuscript by the journal, the quality of the
peer review process, and whether the editor or peer re-
viewers had asked them to change any aspects of their
study in a way that deviated from what was planned in
their trial protocol. They were also asked specific ques-
tions about changes to the primary outcome measure(s)
and/or the analysis of the primary outcome, additional
analyses not included in the original manuscript and
whether they had been asked to modify or change their
overall conclusions. Authors were asked to comment on
the nature of the changes requested in free-text boxes
(see Additional file 4).
The invitation emails were sent out in a batch each
month, approximately 6 weeks after publication of the
journal articles. We inserted the reference to their trial
publication in the invitation email to ensure that we could
link author responses to individual journal articles. Partici-
pants were informed that all responses would be treated
in the strictest confidence and that we would not identify
any individual responses. A reminder email was sent
2 weeks after the original email was sent, to those who did
not respond to the original request. A second reminder
was sent 2 weeks after sending the first reminder.
Data extraction and analysis
Key information was extracted from each eligible report
of a randomised trial for which the corresponding au-
thor had completed the online survey. After piloting of
the data extraction form data extraction was carried out
by one reviewer (OA); any uncertainties were resolved
by discussion with a second reviewer (SH). We extracted
information on the trial design, single or multicentre,
number of study arms, number of participants, disease
area, type of intervention, specification of the primary
outcome and direction of the observed effect, trial regis-
tration and source of funding. We summarised the char-
acteristics of the primary reports of randomised trials
using proportions, median and interquartile range (IQR).
Similarly, authors’ responses to the online survey were
summarised using proportions, number, mean, standard
deviation, median and interquartile range.
The primary analysis focussed on the responses to the
online survey and the nature and extent of changes made
to manuscripts by authors as part of the peer review
process; in particular, in relation to the reporting of the
primary outcome(s) and statistical analyses, how often the
authors followed peer reviewer requests, and their main
motivation for doing so. We assessed whether requested
changes or modifications to the primary outcome(s) and
statistical analysis were related to the type of journal
(general/specialty), type of intervention (drug/non-drug),
source of funding (industry/non-industry), or result of the
primary outcome (significant/non-significant) using the
chi-squared test or Fisher’s exact test as appropriate.
We also carried out a semi-qualitative analysis of free-
text information provided by authors on changes and
clarifications requested by peer reviewers and the extent
to which authors responded to these requests. Two re-
viewers (CW, KL) first developed preliminary codes
based on the questions posed and a screening of the
free-text material. The free-text material was then
systematically assigned to codes; if necessary codes were
revised or new codes added.
Results
The search identified 2106 possible reports of rando-
mised trials published in the top six general medical
journals and top 12 specialty journals between May 2014
and April 2015. After screening the full-text articles we
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identified 893 primary reports of randomised trials, for
which 258 (29%) authors completed the online survey
(Table 1). The response rate by journal ranged from 11%
(Journal of the American College of Cardiology) to 56%
(PLoS Medicine).
Characteristics of primary reports of randomised trials
Table 2 shows the general characteristics of the 258
reports of randomised trials whose authors completed
the online survey. The majority of trials were multi-
centre (n = 191; 74%), parallel group (n = 225; 87%),
with two study groups (n = 202; 78%). The median
sample size was 325 participants (IQR 138 to 1010).
About half of the trials assessed drug interventions
(n = 127; 49%), 23% (n = 59) surgical or procedural in-
terventions and 16% (n = 40) behavioural or educa-
tional interventions. The primary outcome was clearly
defined in 92% (n = 238) of trial reports, of which the
estimated treatment effect was reported as statistically
significant (P < 0.05) in 49% (n = 116). Most trials re-
ported the trial registration number (n = 235; 91%)
and around half (n = 141; 55%) gave a journal refer-
ence for the trial protocol; more than half (n = 159;
62%) were non-industry funded.
Response to online survey by authors of primary reports
of randomised trials
Tables 3 and 4 summarise the authors’ responses to the
online survey, and the nature and extent of changes
made to manuscripts by authors as part of the peer
Table 2 Characteristics of primary reports of randomised trials
(n = 258)
Characteristic n = 258
Journal type
General medical 118 (46%)
Specialty 140 (54%)
Most common specialties
Oncology 44 (17%)
Cardiology 42 (16%)
Paediatrics 26 (10%)
Anaesthesia 22 (8%)
Public health 18 (7%)
Most common countries where trial was conducted
USA 40 (22%)
UK 27 (15%)
Netherlands 16 (9%)
Australia 4 (2%)
Not reported 38 (20%)
Trial designa
Parallel 225 (86.5%)
Cluster 16 (6%)
Factorial 11 (4%)
Crossover 8 (3%)
Split-body 1 (0.5%)
Intervention
Drug 127 (49%)
Surgery/procedure 59 (23%)
Behavioural/education 40 (16%)
Biological/vaccine 12 (5%)
Device 9 (3%)
Dietary supplement 6 (2%)
Other 5 (2%)
Study centres
Single 46 (18%)
Multiple 191 (74%)
Unclear 21 (8%)
Number of intervention groups
2 202 (78%)
3 35 (13.5%)
4 20 (8%)
> 4 1 (0.5)
Median sample size (IQR)b 325 (138 to 1010)
10 to 90 percentile (60 to 2485)
Primary outcome clearly defined
Defined 238 (92%)
Not defined 20 (8%)
Table 2 Characteristics of primary reports of randomised trials
(n = 258) (Continued)
Characteristic n = 258
Statistical significance of primary outcome (where defined)c
Significant 116 (49%)
Non-significant 122 (51%)
Trial registration
Reported 235 (91%)
Not reported 23 (9%)
Trial protocol accessible
Reported 141 (55%)
Not reported 117 (45%)
Source of funding
Solely industry 52 (20%)
Part industry 27 (10%)
Non-industry 159 (62%)
No funding 7 (3%)
Not reported 13 (5%)
aMore than one trial design is applicable (n = 3), bExcluding cluster randomised
trials (n = 242), cPrimary outcome clearly defined (n = 238).
IQR interquartile range
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review process in relation to the reporting of the primary
outcome(s) and statistical analyses. The majority of au-
thors responded that they were satisfied with the hand-
ling of their manuscript by the journal (mean 8.6, SD
1.5) and the quality of peer review (mean 8.5, SD 1.5).
Fourteen percent (n = 36) of authors responded that the
editor or peer reviewers asked them to change an aspect
of their study in way that deviated from what was
planned in the trial protocol.
Only eight authors (3%) said that the editor or peer re-
viewers asked them to change or clarify the trial’s
primary outcome, but about a quarter (n = 69; 27%) re-
ported that they had been asked to change or clarify the
statistical analysis of the primary outcome. Most of those
who were asked to change or clarify the trial’s primary
outcome or statistical analysis responded that they had
fulfilled the request. The main motivation for making
the change to the statistical analysis was either to im-
prove the statistical methods (n = 38; 55%) or to avoid
rejection of paper (n = 30; 44%). Overall, there was no
evidence of association between authors being asked to
change or clarify the trial’s primary outcome and/or stat-
istical analysis and whether the trial was published in a
general or specialty journal, investigated a drug or was a
non-drug intervention, or was solely/partly industry
funded versus non-industry funded (Table 5). The pri-
mary outcome was more likely to be statistically signifi-
cant where authors responded that they had been asked
to change or clarify the trial’s primary outcome; however,
the number of responses was very small (six out of eight
responses; 86%). Conversely, requests for changes or
clarification of the statistical analysis of the primary out-
come were more common (40 out of 69 responses; 60%)
for trials with non-significant primary outcomes.
One third (n = 94; 36%) of authors responded that
they were asked to include additional analyses. Again,
most authors (n = 83; 88%) had complied with the re-
quest with the main motivation being to avoid rejection
of paper (n = 49; 52%). Most of the published articles
(n = 72; 77%) did not indicate that the additional ana-
lyses had not been specified in the protocol. Finally,
around a quarter (n = 60; 23%) of authors were asked to
modify their overall conclusion, in most cases (n = 53;
88%) to provide a more cautious conclusion. Again, the
majority fulfilled the request, the main motivations be-
ing to improve reporting of the trial (n = 32; 53%) or to
avoid rejection of paper (n = 29; 48%).
Textual analysis of author comments to the online survey
questions
Examination of the free-text information provided by the
eight authors who answered they were asked ‘to change or
clarify the trials primary outcome measure(s)’ showed that
only two referred to true ‘changes’. One author reported
that editors and a peer reviewer “asked us to present just
one primary outcome, despite our protocol specifying two”
(trial 434); another that a reviewer asked that “we change
the primary outcome from average depression severity dur-
ing time in trial to depression severity at the end of treat-
ment” (trial 451). In both cases authors successfully argued
against these requests. Two further authors reported issues
which are actually changes to the statistical analysis of the
primary outcome (methods for imputation of missing data
and adjustment; trials 478 and 584), two were requested to
provide non-pre-specified sensitivity or additional analyses
Table 3 Authors’ responses to online survey (n = 258)
Survey responses n = 258
1. How satisfied have you been with the overall handling of your
manuscript by the journal? (1 = very unsatisfactory to 10 = very
satisfactory)
Mean (SD) 8.6 (1.5)
Median 9.0
Min – max 1–10
2. How would you rate the overall quality of the peer review of your
manuscript? (1 = very low to 10 = very high)
Mean (SD) 8.5 (1.5)
Median 9.0
Min – max 1–10
3. In getting your manuscript published, did the editor or peer reviewers
ask you to change any aspects of your study so that it was different
from what was planned in your trial protocol?
Yes 36 (14%)
No 222 (86%)
4. Did the editor or peer reviewers ask you to change or clarify the trial’s
primary outcomes measure(s)?
Yes 8 (3%)
No 250 (97%)
5. Did the editors or peer reviewers ask you to change or clarify the
statistical analysis of your primary outcome measure(s)?
Yes 69 (27%)
No 189 (73%)
6. Were you asked to include any additional analyses that had not been
included in the original manuscript?
Yes 94 (36%)
No 164 (64%)
7. Were you asked to modify your overall conclusions?
Yes 60 (23%)
No 198 (77%)
8. Did you register your trial in a trial registry?
Yes 249 (96.5%)
No 9 (3.5%)
9. Did you publish the protocol of this trial in a journal?
Yes 136 (53%)
No 122 (47%)
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(trials 599 and 328). In the two remaining cases the short
information provided suggested that the submitted
manuscript had insufficiently defined the primary out-
come (trials 396 and 513). True changes requested in the
statistical analysis of the primary outcome most often
concerned addition to or changes of methods to impute
missing data (n = 14), or of the statistical model or test
(n = 11), and less frequently to analysis populations or
adjustment issues. More often, however, editors and re-
viewers requested clarification of statistical methods or pre-
sentations (see Table 6 for examples of free-text responses).
Free-text responses to the question on additional ana-
lyses requested were typically short. The request most
often mentioned explicitly (n = 29) was for additional
subgroup analyses. A further 20 authors simply said they
were asked for additional analyses. A smaller number of
requests can be summarised as for sensitivity analyses to
check the robustness of findings, or for presentation of
additional data. Twenty authors had been asked to draw
more cautious conclusions; a further 20 reported a var-
iety of specific changes which did not make conclusions
more positive or negative. Four others were asked to
draw stronger negative conclusions, one to draw more
positive conclusions in a trial not finding expected
differences; the remainder did not give a reason.
Discussion
Summary of main findings
This study provides a unique opportunity to investigate
the influence of the peer review process within high-
Table 4 Type of change or clarification requested to primary outcome and/or statistical analysis
Sub-questions 4a. Change or clarify the trial’s
primary outcome measures?
(yes, n = 8)
5a. Change or clarify the
statistical analysis?
(yes, n = 69)
6a. Include any
additional analyses?
(yes, n = 94)
7a. Modify the overall
conclusion?
(yes, n = 60)
Who requested the change? n (%)a
Editor 3 (38%) 22 (32%) 29 (31%) 35 (58%)
Reviewer 8 (100%) 39 (57%) 77 (82%) 31 (52%)
Statistician 0 (0%) 32 (46%) 21 (22%) 6 (10%)
Do not know 0 (0%) 2 (3%) 0 (0%) 2 (3%)
What changes or clarifications were requested? n (%)a
Change of the primary outcome
measure
2 (25%) n/a n/a n/a
Clarification of the primary outcome
measure
2 (25%) n/a n/a n/a
More cautious conclusion n/a n/a n/a 53 (88%)
Stronger conclusion n/a n/a n/a 2 (3%)
Other 4 (50%) n/a n/a 5 (8%)
Did you fulfil the request? n (%)
Yes 5 (62.5%) 66 (96%) 83 (88%) 54 (90%)
No 3 (37.5%) 3 (4%) 11 (12%) 6 (10%)
What was your main motivation to fulfil the request? n (%)a
Improvement of the reporting of
the trial
4 (50%) n/a n/a 32 (53%)
Improvement of the statistical
methods/analysis
n/a 38 (55%) 30 (32%) n/a
Avoiding rejection of the paper 2 (25%) 30 (44%) 49 (52%) 29 (48%)
Other 3 (38%) 16 (23%) 31 (33%) 4 (7%)
How did you judge the request? (1 = not problematic to 10 = very problematic)
Mean (SD) 6.8 (3.1) 3.6 (2.4) 3.7 (2.6) 3.5 (2.2)
Median 7.5 3.0 3.0 3.0
Range 2–10 1–10 1–10 1–10
Does the published article indicate that the analyses have not been pre-specified in the protocol? n (%)
Yes n/a n/a 22 (23%) n/a
No 72 (77%)
aMultiple answers possible
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impact medical and specialty journals on the reporting
of primary outcome(s) and statistical analyses in reports
of randomised trials. Textual analysis of author com-
ments from the online survey provides insight into the
types of changes or modifications made by authors as
part of the peer review process and the rationale behind
these changes.
In our study, most authors who took part in the online
survey responded positively regarding the overall hand-
ling and overall quality of peer review of their manu-
script. We found evidence of journal editors or peer
reviewers asking authors to change or clarify the trial’s
primary outcome, in only eight out of the 258 (3%) pub-
lished reports where authors responded to the online
survey, which is encouraging given concerns regarding
bias associated with selective reporting of primary
outcomes in favour of significant outcomes [11]. We
found some evidence of authors being asked to make
changes to the statistical analysis of the primary out-
come; however, in most cases these requests were in
fact for clarifications of the existing methods, the main
motivation being to either improve reporting of the
statistical methods or to avoid rejection by the journal.
Overall, we found no association between authors being
asked to make these changes and the type of journal,
intervention, significance of the primary outcome, or
funding source. Some authors reported being asked to
modify their overall conclusion, in most cases to
provide a more cautious conclusion avoiding spin in
interpretation of the trial results [10]. However, some
changes requested as part of the peer review process
were more concerning, whereby authors were asked to
Table 5 Association between whether editors or peer reviewers asked for changes or clarifications to the primary outcome(s) and/
or statistical analysis and specific journal and trial characteristics
4. Did the editor or peer reviewers ask you to change or clarify
the trial`s primary outcomes measure(s)?
Yes No Fisher’s
exact test
P value
(n = 8) (n = 250)
Type of journal
General 3 (38%) 115 (46%) 0.73 0.46
Specialty 5 (62%) 135 (54%)
Type of intervention
Drug 2 (25%) 125 (50%) 0.28 0.15
Non-drug 6 (75%) 125 (50%)
Statistical significance of primary outcome (where defined)a
Significant 6 (86%) 110 (48%) 0.06 0.05
Non-significant 1 (14%) 121 (52%)
Funding sourceb
Sole/part industry 1 (14%) 78 (34%) 0.43 0.26
Non-industry 6 (86%) 153 (66%)
5. Did the editors or peer reviewers ask you to change or clarify
the statistical analysis of your primary outcome measure(s)?
Yes (n = 69) No (n = 189) Chi2 test P value
Type of journal
General 31 (45%) 87 (46%) 0.02 0.88
Specialty 38 (55%) 102 (54%)
Type of intervention
Drug 28 (41%) 99 (52%) 2.82 0.09
Non-drug 41 (59%) 90 (48%)
Statistical significance of primary outcome (where defined)a
Significant 27 (40%) 89 (52%) 2.66 0.10
Non-significant 40 (60%) 82 (48%)
Funding sourceb
Sole/part industry 17 (26%) 62 (36%) 1.20 0.16
Non-industry 48 (74%) 111 (64%)
aPrimary outcome clearly defined (n = 238)
bSole/part industry funded and non-industry funded (n = 238)
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include additional analyses, such as subgroup analyses, that
had not been included in the original manuscript, of which
the majority were not pre-specified in the trial protocol.
This is concerning as these additional analyses could be
driven by an existing knowledge of the data, or the inter-
ests of the reader, rather than the primary focus of the
study [12]. While the Consolidated Standards of Reporting
Trials (CONSORT) Statement does not preclude add-
itional analyses being performed it does stress the import-
ance of distinguishing those which were pre-specified in
the trial protocol and those which are exploratory [13]. It
is, therefore, concerning that most of the reported changes
to analyses were not reported as post hoc.
Comparison with other studies
We are not aware of other studies specifically looking
at the impact of the peer review process on the report-
ing of the primary outcome and statistical analyses of
randomised trials. Other studies on the impact of peer
review have predominantly focussed on the editorial
process, such as the use of reporting checklists, blind-
ing of peer reviewers [14, 15], or the implementation of
training strategies for peer reviewers [16]. A number of
studies have looked at the selective reporting of pri-
mary outcomes [11] or switching of outcomes from
either the trial registry [17–19], or trial protocol [20]
and the published manuscript. The COMPare study [21]
systematically tracked the switching of outcomes in 67
clinical trials published in the top five medical journals
(October 2015 to January 2016) to compare trial outcomes
reported in the trial registry or protocol with those
reported in the published article. Of the 67 trials, they
identified 354 pre-specified outcomes that were not
reported in the published manuscript and 357 new non-
pre-specified outcomes that were silently added. The
COMPare study looked at all trial outcomes and did not
differentiate between primary and secondary outcomes.
Limitations
Our study has several limitations. First, despite sending
two reminder emails our response rate to the online sur-
vey was still relatively low at 29% and, therefore, we do
not know about those who did not respond. One might
expect both that those with more negative experiences
might have been more likely to respond to the survey; or
that people who experienced a positive spin after peer
review were less likely to respond. Yet, our survey
showed that most authors were happy with overall qual-
ity and handling of their manuscript as part of the peer
review progress. Conversely, it is possible that our find-
ings might present an overly positive picture as we fo-
cussed on authors whose manuscript had recently been
accepted by a high-impact journal. Open peer review,
whereby the peer reviewer’s comments are included
alongside the published article would allow a more
complete assessment of this problem, without the chal-
lenge of low response rates.
Due to the nature of our study, we do not have informa-
tion on the influence of peer review on the reporting of
primary outcome(s) and statistical analyses for those man-
uscripts which were subsequently rejected by the journal.
Finally, our study focussed specifically on high-impact jour-
nals where one might expect the journal editors and peer
reviewers to be more experienced and more likely to iden-
tify potential problems. It is unclear the extent to which
these findings are generalizable to other journals with po-
tentially less experienced editors and peer reviewers.
Conclusion
Overall, we found little evidence of a negative impact of
the peer review process in terms of selective reporting of
primary outcome(s). Most changes requested as part of
the peer review process resulted in improvements to the
trial manuscript, such as improving clarity of the statis-
tical methods and providing more cautious conclusions.
However, some requested changes could be deemed in-
appropriate and could have a negative impact on report-
ing in the final publication, such as the request to add
non-pre-specified additional analyses.
Table 6 Example of free-text answers provided by authors re-
garding changes or clarifications of the statistical analysis of the
primary outcome
Changes of methods to impute missing data
“….they asked us to include the multiple imputation data for the
primary outcome, which was a sensitivity analysis, in the abstract and
up front in the results. We ensured that all of the data were presented
and it made almost no difference to the results so we were OK with it.”
(case 478) “Requested that we change report of primary outcome to
use multiple imputation of missing data.” (case 454)
Change of statistical model/methods
“We were asked to use a different type of regression model and
different independent variables than we had stated in our trial protocol.”
(case 556)
“They recommended a different statistical approach. In the end we felt
it was a better approach, and it did not change the overall intent or
purpose of the study, but it was different than what we originally
had planned in our protocol.” (case 450)
Analysis populations and adjustment issues
“To include all patients after randomisation in ITT and to delete the
per-protocol analysis from the main text. Also, to present the baseline
adjusted analysis as primary analysis and the analysis adjusted for
unbalanced baseline characteristic as additional analysis.” (case 509)
Clarifications or presentation issues
“The editors requested clarification on a planned non-inferiority analysis.”
(case 651)
“Clarify statistical methods used.” (case 563)
“Change mean and SD into median and 95% CI in case of skewed
distributions.” (case 462)
CI confidence interval, SD standard deviation
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